-
An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.
-
The Inflation Reduction Act gives Medicare historic new powers to lower prescription drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.
-
A recently approved economic package will lower out-of-pocket costs for some patients. Many who rely on the costly medication say the measure doesn’t go far enough.